{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 32, "transaction_limit": 160, "filters": {"q": "", "ticker": "GLUE", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 32, "acquisition_count": 10, "disposal_count": 22, "acquisition_value": 512861.35, "acquisition_value_label": "$512.9K", "disposal_value": 1948772.5938, "disposal_value_label": "$1.9M", "net_value": -1435911.2438, "net_value_label": "$-1.4M", "flow_tone": "negative", "largest_value_label": "$642.7K", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 32, "value": "2461633.9438", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$2.5M"}], "days": [{"transaction_date": "2026-06-23", "acquisitions": 3, "disposals": 6, "total": 9, "bar_width": 100.0}, {"transaction_date": "2026-06-24", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 33.3}, {"transaction_date": "2026-06-29", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 66.7}, {"transaction_date": "2026-06-30", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 33.3}, {"transaction_date": "2026-07-01", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 33.3}, {"transaction_date": "2026-07-06", "acquisitions": 1, "disposals": 3, "total": 4, "bar_width": 44.4}, {"transaction_date": "2026-07-15", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 33.3}, {"transaction_date": "2026-07-16", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 11.1}], "side_mix": {"acquisitions": 10, "disposals": 22, "acquisition_share": 31.2, "disposal_share": 68.8}}, "company_flows": [{"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "acquisitions": 10, "disposals": 22, "acquired_value": 512861.35, "acquired_value_label": "$512.9K", "disposed_value": 1948772.5938, "disposed_value_label": "$1.9M", "net_value": -1435911.2438, "net_value_label": "$-1.4M", "acquisition_share": 31.2, "disposal_share": 68.8, "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}], "company_overview": [{"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-16", "filings": 32, "acquisitions": 10, "disposals": 22, "acquired_value": 512861.35, "acquired_value_label": "$512.9K", "disposed_value": 1948772.5938, "disposed_value_label": "$1.9M", "net_value": -1435911.2438, "net_value_label": "$-1.4M", "acquisition_share": 31.2, "disposal_share": 68.8, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}], "transactions": [{"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-16", "executive": "WARMUTH, MARKUS", "executive_title": "Director, President & CEO", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 9500.0, "share_price": 23.1809, "transaction_value": 220218.55, "fetched_at": "2026-07-31T10:52:40.239187+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "CHAMPOUX, JENNIFER", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 4351.0, "share_price": 23.3808, "transaction_value": 101729.8608, "fetched_at": "2026-07-31T10:52:40.245898+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "CHAMPOUX, JENNIFER", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 4351.0, "share_price": 3.98, "transaction_value": 17316.98, "fetched_at": "2026-07-31T10:52:40.248161+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-15", "executive": "CHAMPOUX, JENNIFER", "executive_title": "Chief Operating Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 4351.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T10:52:40.243556+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "TOWNSON, SHARON", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5600.0, "share_price": 23.2495, "transaction_value": 130197.2, "fetched_at": "2026-07-27T21:58:23.419843+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "TOWNSON, SHARON", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 6000.0, "share_price": 6.14, "transaction_value": 36840.0, "fetched_at": "2026-07-27T21:58:23.415496+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "TOWNSON, SHARON", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 400.0, "share_price": 24.13, "transaction_value": 9652.0, "fetched_at": "2026-07-27T21:58:23.418403+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-06", "executive": "TOWNSON, SHARON", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 6000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-27T21:58:23.416929+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BEHBAHANI, ALI", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 15000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T11:05:18.661434+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BEHBAHANI, ALI", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 15000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T11:05:18.663053+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "BEHBAHANI, ALI", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 1000000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-22T11:05:18.664864+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 5407.0, "share_price": 24.5, "transaction_value": 132471.5, "fetched_at": "2026-07-20T21:53:57.115074+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 5407.0, "share_price": 13.41, "transaction_value": 72507.87, "fetched_at": "2026-07-20T21:53:57.118567+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 5407.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T21:53:57.116920+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "MANNING, ANTHONY M.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 23.11, "transaction_value": 231100.0, "fetched_at": "2026-07-20T21:53:57.120326+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 6000.0, "share_price": 22.95, "transaction_value": 137700.0, "fetched_at": "2026-07-20T21:53:57.122374+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 6000.0, "share_price": 7.56, "transaction_value": 45360.0, "fetched_at": "2026-07-20T21:53:57.124286+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "MANNING, ANTHONY M.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 10000.0, "share_price": 4.16, "transaction_value": 41600.0, "fetched_at": "2026-07-20T21:53:57.126063+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 6000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T21:53:57.127638+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "MANNING, ANTHONY M.", "executive_title": "Director", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 10000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-20T21:53:57.129414+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 30000.0, "share_price": 21.4227, "transaction_value": 642681.0, "fetched_at": "2026-07-15T10:59:39.002422+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 30000.0, "share_price": 7.56, "transaction_value": 226800.0, "fetched_at": "2026-07-15T10:59:39.000978+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 30000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-15T10:59:38.999603+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 11845.0, "share_price": 20.2214, "transaction_value": 239522.483, "fetched_at": "2026-07-13T21:47:55.660930+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "TOWNSON, SHARON", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 3000.0, "share_price": 20.0, "transaction_value": 60000.0, "fetched_at": "2026-07-13T21:47:55.658131+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 6000.0, "share_price": 7.56, "transaction_value": 45360.0, "fetched_at": "2026-07-13T21:47:55.669179+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "CHAMPOUX, JENNIFER", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2175.0, "share_price": 20.0, "transaction_value": 43500.0, "fetched_at": "2026-07-13T21:47:55.664911+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "TOWNSON, SHARON", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 3000.0, "share_price": 6.14, "transaction_value": 18420.0, "fetched_at": "2026-07-13T21:47:55.667763+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "CHAMPOUX, JENNIFER", "executive_title": "Chief Operating Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2175.0, "share_price": 3.98, "transaction_value": 8656.5, "fetched_at": "2026-07-13T21:47:55.663582+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "CHAMPOUX, JENNIFER", "executive_title": "Chief Operating Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 2175.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:47:55.666257+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "JANKU, FILIP", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 6000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:47:55.662274+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}, {"symbol": "GLUE", "name": "Monte Rosa Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "TOWNSON, SHARON", "executive_title": "Chief Scientific Officer", "security_type": "Stock Option (Right to Buy)", "side_code": "D", "side": "Disposal", "shares": 3000.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-13T21:47:55.659601+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/glue/", "research_links": {"chart": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/", "report": "/terminal/56535628-7b26-43f9-9d73-60978a9eabdf/report/", "factor": "/factors/ticker/56535628-7b26-43f9-9d73-60978a9eabdf/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}